4. Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Adults

BACKGROUND: Immunocompromised (IC) populations are at increased risk of developing herpes zoster (HZ) due to disease- and/or therapy-induced immunosuppression. The adjuvanted recombinant zoster vaccine (RZV) has demonstrated 68.2% efficacy in preventing HZ in autologous hematopoietic stem cell trans...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Dagnew, Alemnew F, Vink, Peter, Drame, Mamadou, Willer, David, Salaun, Bruno, Schuind, Anne
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Oral Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7776102/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa417.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados